Abstract:Background: Protein theranostics integrate both diagnostic and treatment functions on a single disease-targeting protein. However, the preparation of these multimodal agents remains a major challenge. Ideally, conventional recombinant proteins should be used as starting materials for modification with the desired detection and therapeutic functionalities, but simple chemical strategies that allow the introduction of two different modifications into a protein in a site-specific manner are not currently available. We recently discovered two highly efficient peptide ligases, namely butelase-1 and VyPAL2. Although both ligate at asparaginyl peptide bonds, these two enzymes are bio-orthogonal with distinguishable substrate specificities, which can be exploited to introduce distinct modifications onto a protein.Methods: We quantified substrate specificity differences between butelase-1 and VyPAL2, which provide orthogonality for a tandem ligation method for protein dual modifications. Recombinant proteins or synthetic peptides engineered with the preferred recognition motifs of butelase-1 and VyPAL2 at their respective C- and N-terminal ends could be modified consecutively by the action of the two ligases.Results: Using this method, we modified an EGFR-targeting affibody with a fluorescein tag and a mitochondrion-lytic peptide at its respective N- and C-terminal ends. The dual-labeled protein was found to be a selective bioimaging and cytotoxic agent for EGFR-positive A431 cancer cells. In addition, the method was used to prepare a cyclic form of the affibody conjugated with doxorubicin. Both modified affibodies showed increased cytotoxicity to A431 cells by 10- and 100-fold compared to unconjugated doxorubicin and the free peptide, respectively.Conclusion: Bio-orthogonal tandem ligation using two asparaginyl peptide ligases with differential substrate specificities is a straightforward approach for the preparation of multifunctional protein biologics as potential theranostics.

Enzymatic Construction of Protein Polymer/Polyprotein Using OaAEP1 and TEV Protease

Enzymatic Biosynthesis and Immobilization of Polyprotein Verified at the Single-Molecule Level.

OaAEP1-Mediated Enzymatic Synthesis and Immobilization of Polymerized Protein for Single-Molecule Force Spectroscopy

One-step Asparaginyl Endopeptidase (Oaaep1)-Based Protein Immobilization for Single-Molecule Force Spectroscopy.

Design of a recombinant asparaginyl ligase for site-specific modification using efficient recognition and nucleophile motifs

SpyTag/SpyCatcher Molecular Cyclization Confers Protein Stability and Resilience to Aggregation

SpyTag/SpyCatcher molecular cyclization confers protein stability and resilience to aggregation.

Protein Editing using a Concerted Transposition Reaction

Characterization of Thermostable and Chimeric Enzymes Via Isopeptide Bond-Mediated Molecular Cyclization.

Tertiary amide bond formation by an engineered asparaginyl ligase

Engineering protein theranostics using bio-orthogonal asparaginyl peptide ligases

OaAEP1-mediated PNA-protein Conjugation Enables Erasable Imaging of Membrane Proteins

Enzymatic Protein Immobilization on Amino-Functionalized Nanoparticles

Programmable Protein Topology Via SpyCatcher‐SpyTag Chemistry in One‐pot Cell‐free Expression System

Sortase-catalyzed Initiator Attachment Enables High Yield Growth of a Stealth Polymer from the C Terminus of a Protein.

Automated Flow Peptide Synthesis Enables Engineering of Proteins with Stabilized Transient Binding Pockets

Topology engineering via protein catenane construction to strengthen an industrial biocatalyst

Development of Powerful Auxiliary-Mediated Ligation To Facilitate Rapid Protein Assembly

Design and Construction of an Effective Expression System with Aldehyde Tag for Site-Specific Enzyme Immobilization

Combination of Click Chemistry and Enzymatic Ligation for Stable and Efficient Protein Immobilization for Single-Molecule Force Spectroscopy

Facile Method of Constructing Polyproteins for Single-Molecule Force Spectroscopy Studies.